Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1065 - 1072 of 11439 results
Pillsbury White Collar Pro Jumps To Mintz In San Francisco
May 22, 2023| News
New York City Council Passes Prohibition on “Height” and “Weight” Discrimination
May 19, 2023| Blog| Viewpoint
No More Mr. Nice BI: Reg BI Violation Leads to Expulsion for FINRA Member Firm
May 19, 2023| Blog| Viewpoint
With More Than 400 Clients In San Francisco, Mintz Prioritizes Office Growth
May 19, 2023| News
SEC Adopts New Share Repurchase Disclosure Rules
May 18, 2023| Alert| Viewpoint
Get To Know An FCBA MEMBER
May 18, 2023| News
Justices’ Denial Of CWA Citizen Suit Petition Could Shape State Enforcement
May 18, 2023| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.